LUZ GARCIA: Open Payments
NPI 1740575687 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 20 payments from 10 companies in 2025. Trend: 2023 $955 · 2024 $628 · 2025 $584
Food & beverage: $584
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $232 |
| Novo Nordisk Inc | 4 | $91 |
| Amgen Inc. | 5 | $90 |
| Dexcom, Inc. | 2 | $36 |
| ABBVIE INC. | 2 | $31 |
| Medtronic, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| PFIZER INC. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $15 |
Products named: JARDIANCE, OTEZLA, Dexcom G6 Transmitter, Ozempic, VRAYLAR, VENASEAL, CAPLYTA, Wegovy.
Industry payments across CA — which companies pay providers there.
